New drug approved for travellers' diarrhoea | The Daily Star
12:00 AM, November 25, 2018 / LAST MODIFIED: 12:00 AM, November 25, 2018

New drug approved for travellers' diarrhoea

The oral antibacterial Rifamycin (marketed as Aemcolo) has been approved to treat travellers' diarrhoea driven by non-invasive strains of E. coli. The drug, an RNA-polymerase inhibitor, is indicated for adults whose condition is not complicated by blood in the stool or fever.

In a study of 250 adults, Rifamycin significantly reduced travellers' diarrhoea symptoms compared with placebo. Drug safety was tested in two clinical trials of some 620 patients. Constipation and headache were the most common side effects.

The tablets are absorbed directly into the colon and should not affect beneficial bacteria in the upper gastro-intestinal tract, according to the manufacturer.

Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.

Grameenphone:
Type START <space> BR and send SMS it to 22222

Robi:
Type START <space> BR and send SMS it to 2222


Banglalink:
Type START <space> BR and send SMS it to 2225

Leave your comments

Top News

Top News

Top